Abstract:Background
High‐output double enterostomies (DESs) and enteroatmospheric fistulas (EAFs) of the small bowel account for substantial patient morbidity and mortality. Management may include parenteral nutrition (PN) and prolonged admissions, at high cost. Reinfusion of chyme into the distal bowel is a proposed therapeutic alternative when the distal DES limb is accessible; however, standardized information on this technique is required. This review aimed to critically assess the literature regarding chyme reinfu… Show more
“…PN meets nutritional demands and reduces gastrointestinal secretions by 30%–50%, thereby minimizing the incidence of dehydration and electrolyte deficiencies [1,2,6]. However, PN carries significant risks including line sepsis and liver dysfunction, and is resource intensive [8,12,13].…”
Section: Discussionmentioning
confidence: 99%
“…However, PN carries significant risks including line sepsis and liver dysfunction, and is resource intensive [8,12,13].…”
Section: Comparison With Other Methods Advantages and Disadvantages Difficulties And Complicationsmentioning
confidence: 99%
“…Chyme reinfusion (CR) was promoted by Levy et al as extracorporeal reinfusion of the proximal fistula output into the distal bowel [5,9]. Therapeutic effects include weight gain, improved liver function, normalized fluid and electrolyte balance and distal bowel rehabilitation [10], as well as potential cessation of PN and cost effectiveness [2,5,7–9,11,12].…”
Enterocutaneous fistulas (ECFs) are challenging to manage and associated with high morbidity and mortality. Mortality ranges from 5% to 20%, with sepsis being the leading cause of death. Factors influencing the outcomes of patients with ECF include fistula anatomy, output volumes and patient comorbidities [1,2]. Specialist intestinal failure centres have improved outcomes significantly and have decreased mortality [1,3]. Chapman et al. described the four management principles for ECF as: source control, fluid resuscitation, effluent management and skin protection [4]. Nutrition has also been identified as a keyfactor influencing patient outcomes [1,4]. A high-output ECF (losses >500 ml/day) can result in fluid and electrolyte loss and malnutrition, culminating in intestinal failure [2,5,6]. The gold-standard nutritional support is parenteral nutrition (PN). However, this is associated with significant complications and is resource intensive and expensive [5,7,8].
“…PN meets nutritional demands and reduces gastrointestinal secretions by 30%–50%, thereby minimizing the incidence of dehydration and electrolyte deficiencies [1,2,6]. However, PN carries significant risks including line sepsis and liver dysfunction, and is resource intensive [8,12,13].…”
Section: Discussionmentioning
confidence: 99%
“…However, PN carries significant risks including line sepsis and liver dysfunction, and is resource intensive [8,12,13].…”
Section: Comparison With Other Methods Advantages and Disadvantages Difficulties And Complicationsmentioning
confidence: 99%
“…Chyme reinfusion (CR) was promoted by Levy et al as extracorporeal reinfusion of the proximal fistula output into the distal bowel [5,9]. Therapeutic effects include weight gain, improved liver function, normalized fluid and electrolyte balance and distal bowel rehabilitation [10], as well as potential cessation of PN and cost effectiveness [2,5,7–9,11,12].…”
Enterocutaneous fistulas (ECFs) are challenging to manage and associated with high morbidity and mortality. Mortality ranges from 5% to 20%, with sepsis being the leading cause of death. Factors influencing the outcomes of patients with ECF include fistula anatomy, output volumes and patient comorbidities [1,2]. Specialist intestinal failure centres have improved outcomes significantly and have decreased mortality [1,3]. Chapman et al. described the four management principles for ECF as: source control, fluid resuscitation, effluent management and skin protection [4]. Nutrition has also been identified as a keyfactor influencing patient outcomes [1,4]. A high-output ECF (losses >500 ml/day) can result in fluid and electrolyte loss and malnutrition, culminating in intestinal failure [2,5,6]. The gold-standard nutritional support is parenteral nutrition (PN). However, this is associated with significant complications and is resource intensive and expensive [5,7,8].
“…It was revealed by Mettu et al (27) that fistuloclysis could replace the parenteral nutrition and reduce the cost of nutritional support. For these critically ill surgical patients, fistulaclysis allows early enteral nutrition, which improves prognosis through improvements of intestinal barrier functions and immune states (28,29).…”
Enteroatmospheric fistula (EAF) after open abdomen adds difficulties to the management and increases the morbidity and mortality of patients. As an effective measurement, reconstructing gastrointestinal tract integrity not only reduces digestive juice wasting and wound contamination, but also allows expedient restoration of enteral nutrition and intestinal homeostasis. In this review, we introduce several technologies for the temporary isolation of EAF, including negative pressure wound therapy, fistuloclysis, fistula patch, surgical covered stent, three-dimensional (3D) printing stent, and injection molding stent. The manufacture and implantation procedures of each technique with their pros and cons are described in detail. Moreover, the approach in combination with finger measurement, x-ray imaging, and computerized tomography is used to measure anatomic parameters of fistula and design appropriate 3D printer-recognizable stereolithography files for production of isolation devices. Given the active roles that engineers playing in the technology development, we call on the cooperation between clinicians and engineers and the organization of clinical trials on these techniques.
“…The mortality rate of high output EAFs is as high as 30%, while that of low output EAFs is 6% ( 46 ). EAF presenting in an open abdomen is now common and represents substantial challenges in nutritional support.…”
The management of enterocutaneous fistulas (ECF) can be challenging because of massive fluid loss, which can lead to electrolyte imbalance, severe dehydration, malnutrition and sepsis. Nutritional support plays a key role in the management and successful closure of ECF. The principle of nutritional support for patients with ECF should be giving enteral nutrition (EN) priority, supplemented by parenteral nutrition if necessary. Although total parenteral nutrition (TPN) may be indicated, use of enteral feeding should be advocated as early as possible if patients are tolerant to it, which can protect gut mucosal barrier and prevent bacterial translocation. A variety of methods of enteral nutrition have been developed such as fistuloclysis and relay perfusion. ECF can also be occluded by special devices and then EN can be implemented, including fibrin glue application, Over-The-Scope Clip placement and three-dimensional (3D)-printed patient-personalized fistula stent implantation. However, those above should not be conducted in acute fistulas, because tissues are edematous and perforation could easily occur.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.